Technical failures after pancreas transplants: Why grafts fail and the risk factors - A multivariate analysis

被引:201
作者
Humar, A [1 ]
Ramcharan, T [1 ]
Kandaswamy, R [1 ]
Gruessner, RWG [1 ]
Gruessner, AC [1 ]
Sutherland, DER [1 ]
机构
[1] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA
关键词
pancreas transplants; surgical complications;
D O I
10.1097/01.TP.0000137198.09182.A2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Technical failure (TF) rates remain high after pancreas transplants; while rates have decreased over the last decade, more than 10% of all pancreas grafts continue to be lost due to technical reasons. We performed a multivariate analysis to determine causes and risk factors for TF of pancreas grafts. Results. Between 1994 and 2003, 937 pancreas transplants were performed at our center in the following transplant categories: simultaneous pancreas-kidney (SPK) (n=327), pancreas after kidney (PAK) (n=399), and pancreas transplant alone (PTA) (n=211). Of these, 123 (13.1%) grafts were lost due to technical reasons (thrombosis, leaks, infections). TF rates were higher for SPK (15.3%) versus PAK (12.2%) or PTA (11.4%), though this was not statistically significant. Thrombosis accounted for 52.0% of all TFs. Other causes were infections (18.7%), pancreatitis (20.3%), leaks (6.5%), and bleeding (2.4%). Thrombosis was the most common cause for TF in all three transplant categories. By multivariate analysis, the following were significant risk factors for TF of the graft: recipient body mass index (BMI) >30kg/m(2) (relative risk [RR] = 2.42, P= 0.0003), preservation time >24 hr (1.87, P= 0.04), cause of donor death other than trauma (RR= 1.58, P=0.04), enteric versus bladder drainage (1.68, P=0.06), and donor BMI >30 kg/m(2) (1.66, P=0.06). Not significant were donor or recipient age, a retransplant, and the category of transplant. Conclusions. TFs remain significant after pancreas transplants. In SPK recipients, TF represents the most common cause of pancreas graft loss. For isolated pancreas transplants, TF is second only to rejection as a cause of graft loss. Increased preservation times and donor or recipient obesity seem to be risk factors. Minimizing these risks factors would be important to try to decrease TF.
引用
收藏
页码:1188 / 1192
页数:5
相关论文
共 16 条
[1]   Obesity favors surgical and infectious complications after renal transplantation [J].
Espejo, B ;
Torrès, A ;
Valentín, M ;
Bueno, B ;
Andrés, A ;
Praga, M ;
Morales, JM .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) :1762-1763
[2]   The surgical risk of pancreas transplantation in the cyclosporine era: An overview [J].
Gruessner, RWG ;
Sutherland, DER ;
Troppmann, C ;
Benedetti, E ;
Hakim, N ;
Dunn, DL ;
Gruessner, AC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1997, 185 (02) :128-144
[3]  
GRUESSNER RWG, 1994, SURG ROUNDS, V17, P383
[4]   Decreased surgical risks of pancreas transplantation in the modern era [J].
Humar, A ;
Kandaswamy, R ;
Granger, D ;
Gruessner, RW ;
Gruessner, AC ;
Sutherland, DER .
ANNALS OF SURGERY, 2000, 231 (02) :269-275
[5]   Prolonged preservation increases surgical complications after pancreas transplants [J].
Humar, A ;
Kandaswamy, R ;
Drangstveit, MB ;
Parr, E ;
Gruessner, AG ;
Sutherland, DER .
SURGERY, 2000, 127 (05) :545-551
[6]   Chronic rejection: The next major challenge for pancreas transplant recipients [J].
Humar, A ;
Khwaja, K ;
Ramcharan, T ;
Asolati, M ;
Kandaswamy, R ;
Gruessner, RWG ;
Sutherland, DER ;
Gruessner, AC .
TRANSPLANTATION, 2003, 76 (06) :918-923
[7]   Vascular graft thrombosis after pancreas transplantation: Comparison of the FK 506 and cyclosporine eras [J].
Kandaswamy, R ;
Humar, A ;
Gruessner, AC ;
Harmon, JV ;
Granger, DK ;
Lynch, S ;
Sutherland, DER ;
Gruessner, RW .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :602-603
[8]   Risk factors for intra-abdominal infection after pancreas transplantation [J].
Knight, RJ ;
Bodian, C ;
Rodriguez-Laiz, G ;
Guy, SR ;
Fishbein, TM .
AMERICAN JOURNAL OF SURGERY, 2000, 179 (02) :99-102
[9]   Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients [J].
Paya, C ;
Humar, A ;
Dominguez, E ;
Washburn, K ;
Blumberg, E ;
Alexander, B ;
Freeman, R ;
Heaton, N ;
Pescovitz, MD .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (04) :611-620
[10]   Surgical complications after pancreas transplantation with portal-enteric drainage [J].
Reddy, KS ;
Stratta, RJ ;
Shokouh-Amiri, MH ;
Alloway, R ;
Egidi, MF ;
Gaber, AO .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (03) :305-313